User profiles for Serena M. Bagnasco
 | Serena BagnascoJohns Hopkins School of Medicine Verified email at jhmi.edu Cited by 10807 |
Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker
…, M Bobadilla, CD Cohen, SM Bagnasco… - Science translational …, 2015 - science.org
Chronic kidney disease (CKD) affects 8 to 16% people worldwide, with an increasing incidence
and prevalence of end-stage kidney disease (ESKD). The effective management of CKD …
and prevalence of end-stage kidney disease (ESKD). The effective management of CKD …
[HTML][HTML] Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury
MT Gandolfo, HR Jang, SM Bagnasco, GJ Ko… - Kidney international, 2009 - Elsevier
T lymphocytes modulate early ischemia-reperfusion injury in the kidney; however, their role
during repair is unknown. We studied the role of TCRβ + CD4 + CD25 + Foxp3 + regulatory T …
during repair is unknown. We studied the role of TCRβ + CD4 + CD25 + Foxp3 + regulatory T …
Tumor regression and allograft rejection after administration of anti–PD-1
EJ Lipson, SM Bagnasco, J Moore Jr… - … England Journal of …, 2016 - Mass Medical Soc
Cancers, especially skin cancers, may develop in patients undergoing solid-organ
transplantation who receive long-term immunosuppression. The use of anti–PD-1 in one …
transplantation who receive long-term immunosuppression. The use of anti–PD-1 in one …
[HTML][HTML] Quantifying renal allograft loss following early antibody-mediated rejection
…, C Wickliffe, BE Lonze, SM Bagnasco… - American journal of …, 2015 - Elsevier
Unlike antibody-mediated rejection (AMR) with clinical features, it remains unclear whether
subclinical AMR should be treated, as its effect on allograft loss is unknown. It is also …
subclinical AMR should be treated, as its effect on allograft loss is unknown. It is also …
Integrative genomics identifies novel associations with APOL1 risk genotypes in black NEPTUNE subjects
…, DB Johnstone, JF O'Toole, SM Bagnasco… - Journal of the …, 2016 - journals.lww.com
APOL1 variants have been associated with renal phenotypes in blacks. To refine clinical
outcomes and discover mechanisms of APOL1-associated kidney injury, we analyzed clinical …
outcomes and discover mechanisms of APOL1-associated kidney injury, we analyzed clinical …
[HTML][HTML] The TonE/TonEBP pathway mediates tonicity-responsive regulation of UT-A urea transporter expression
…, T Peng, JM Sands, SM Bagnasco - Journal of Biological …, 2000 - ASBMB
The rat renal urea transporter UT-A includes four isoforms. UT-A1, UT-A3, and UT-A4 are
transcribed from a single initiation site at the 5′-end of the gene; a distinct internal initiation …
transcribed from a single initiation site at the 5′-end of the gene; a distinct internal initiation …
Induction of aldose reductase and sorbitol in renal inner medullary cells by elevated extracellular NaCl.
SM Bagnasco, S Uchida, RS Balaban… - Proceedings of the …, 1987 - National Acad Sciences
Aldose reductase [aldehyde reductase 2; alditol:NAD(P)+ 1-oxidoreductase, EC 1.1.1.21]
catalyzes conversion of glucose to sorbitol. Although its activity is implicated in the progression …
catalyzes conversion of glucose to sorbitol. Although its activity is implicated in the progression …
[HTML][HTML] Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis
…, GB Appel, A Athavale, MA Atkinson, SM Bagnasco… - Kidney international, 2023 - Elsevier
The diagnosis of nephrotic syndrome relies on clinical presentation and descriptive patterns
of injury on kidney biopsies, but not specific to underlying pathobiology. Consequently, …
of injury on kidney biopsies, but not specific to underlying pathobiology. Consequently, …
Eculizumab and Splenectomy as Salvage Therapy for Severe Antibody-Mediated Rejection After HLA–Incompatible Kidney Transplantation
…, AA Zachary, NN Dagher, SM Bagnasco… - …, 2014 - journals.lww.com
Background Incompatible live donor kidney transplantation is associated with an increased
rate of antibody-mediated rejection (AMR) and subsequent transplant glomerulopathy. For …
rate of antibody-mediated rejection (AMR) and subsequent transplant glomerulopathy. For …
Complement-activating anti-HLA antibodies in kidney transplantation: allograft gene expression profiling and response to treatment
Complement-activating anti-HLA donor-specific antibodies (DSAs) are associated with
impaired kidney transplant outcome; however, whether these antibodies induce a specific …
impaired kidney transplant outcome; however, whether these antibodies induce a specific …